A detailed history of Dimensional Fund Advisors LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 208,273 shares of IRWD stock, worth $735,203. This represents 0.0% of its overall portfolio holdings.

Number of Shares
208,273
Previous 213,619 2.5%
Holding current value
$735,203
Previous $1.39 Million 38.51%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$3.93 - $7.04 $21,009 - $37,635
-5,346 Reduced 2.5%
208,273 $856,000
Q2 2024

Aug 09, 2024

BUY
$5.58 - $8.61 $389,751 - $601,391
69,848 Added 48.58%
213,619 $1.39 Million
Q1 2024

May 10, 2024

SELL
$8.32 - $15.45 $24.4 Million - $45.4 Million
-2,938,040 Reduced 95.33%
143,771 $1.25 Million
Q4 2023

Feb 07, 2024

SELL
$8.79 - $11.51 $21.4 Million - $28 Million
-2,435,165 Reduced 44.14%
3,081,811 $35.3 Million
Q3 2023

Nov 09, 2023

SELL
$8.25 - $11.35 $776,259 - $1.07 Million
-94,092 Reduced 1.68%
5,516,976 $53.1 Million
Q2 2023

Aug 09, 2023

BUY
$10.1 - $11.6 $10.1 Million - $11.6 Million
1,001,989 Added 21.74%
5,611,068 $59.7 Million
Q1 2023

May 12, 2023

BUY
$10.37 - $12.56 $9.82 Million - $11.9 Million
946,481 Added 25.84%
4,609,079 $48.5 Million
Q4 2022

Feb 09, 2023

BUY
$9.9 - $12.43 $3.28 Million - $4.11 Million
330,975 Added 9.93%
3,662,598 $45.4 Million
Q3 2022

Nov 10, 2022

BUY
$10.14 - $12.38 $2.56 Million - $3.12 Million
252,333 Added 8.19%
3,331,623 $34.5 Million
Q2 2022

Aug 12, 2022

BUY
$11.05 - $12.72 $52,598 - $60,547
4,760 Added 0.15%
3,079,290 $35.5 Million
Q1 2022

May 13, 2022

SELL
$10.61 - $12.88 $26,089 - $31,671
-2,459 Reduced 0.08%
3,074,530 $38.7 Million
Q4 2021

Feb 09, 2022

BUY
$10.86 - $13.95 $1.3 Million - $1.67 Million
119,916 Added 4.06%
3,076,989 $35.9 Million
Q3 2021

Nov 12, 2021

BUY
$11.92 - $13.92 $3.31 Million - $3.86 Million
277,543 Added 10.36%
2,957,073 $38.6 Million
Q2 2021

Aug 12, 2021

BUY
$10.16 - $13.11 $7.47 Million - $9.63 Million
734,831 Added 37.79%
2,679,530 $34.5 Million
Q1 2021

May 14, 2021

BUY
$9.04 - $11.86 $5.76 Million - $7.56 Million
637,300 Added 48.75%
1,944,699 $21.7 Million
Q4 2020

Feb 25, 2021

BUY
$9.05 - $12.2 $11.8 Million - $16 Million
1,307,399 New
1,307,399 $14.9 Million

Others Institutions Holding IRWD

About IRONWOOD PHARMACEUTICALS INC


  • Ticker IRWD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 153,231,008
  • Market Cap $541M
  • Description
  • Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...
More about IRWD
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.